- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04093583
Randomized Clinical Trial, Conventional Treatment-controlled, Studying the Efficacy of Plasma Rich in Growth Factor (PRGF®) in Alveolar Ridge Preservation After Simple Exodontia in the Anterior Region of Maxilla.
May 6, 2022 updated by: Fundación Eduardo Anitua
This RCT aims to study the efficacy and safety of PRGF-Endoret in alveolar ridge preservation in the aesthetic zone.
The control group is the spontaneous healing occuring after the suturing of the alveolus.
The primary endpoint is the bone regeneration measured in biopsies obtained from the regenerated alveolar bone.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Anticipated)
46
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mikel Allende, PhD, MBA
- Phone Number: 257 945 16 06 53
- Email: mikel.allende@bti-implant.es
Study Locations
-
-
-
A Coruña, Spain, 15005
- Recruiting
- Clínica Dental González Mosquera
-
Contact:
- Antonio González Mosquera, DDS
-
-
Alava
-
Vitoria-Gasteiz, Alava, Spain, 01005
- Recruiting
- Eduardo Anitua Private Clinic
-
Contact:
- Eduardo Anitua, MD,PhD
-
Sub-Investigator:
- Alia Murias, DDS
-
-
Bizkaia
-
Getxo, Bizkaia, Spain, 48930
- Recruiting
- Clinica dental Murias
-
Contact:
- Alia Murias
-
Principal Investigator:
- Alia Murias
-
-
Viscay
-
Galdakao, Viscay, Spain, 48960
- Recruiting
- Clinica Dental Loroño
-
Contact:
- Joseba Loroño, DDS
-
Principal Investigator:
- Joseba Loroño, DDS
-
Sub-Investigator:
- Markel Loroño, DDS
-
Getxo, Viscay, Spain, 48991
- Not yet recruiting
- Clinica Ereaga
-
Sub-Investigator:
- Alia Murias, DDS
-
Contact:
- Alia Murias, DDS
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- - Subjects of both sexes with an age greater than or equal to 18 years.
- Clinical indication for a simple exodontia in the aesthetic zone (from left 2nd premolar to the right 2nd premolar in the maxilla).
- Need of a dental implant placement in the extraction site.
- Availability to follow-up during the treatment period
- Subjects with non-active periodontal disease.
- Buccal dehiscence < than 25% in the vestibular table
Exclusion Criteria:
- - Presence of an active infection
- Loss of any plate of the socket
- Severe inflammation in the area of the exodontia previous to the intervention
- Have previous diagnosis of a coagulopathy.
- Have previous diagnosis of any autoinmune disease.
- Have received radiotherapy, chemotherapy or immunosuppressive treatments, systemic corticosteroids and/or anticoagulants the 30 days prior to inclusion
- Regular treatment with AINES or other antiinflammatory drugs
- Previous history of chronic hepatitis or heatic cirrhosis
- Positive markers for VHC, AgHBs, VIH I/II or Treponema pallidum
- Uncontrolled diabetes mellitus (Glycosylated hemoglobin higher than 9%)
- Subjects submitted to hemodyalisis
- Presence of malignant tumour, haemangiomas or angioma in the exodontia region.
- Previous history of ischemic cardiopathy in the last year.
- Pregnancy or womens in childbearing age who do not take contraception measures.
- Nursing womens
- Metabolic bone disease
- Ongoing treatment with biphosphonates both through oral or intravenous administration
- Smoking habits (> 10 cigarrettes/day)
- In general, any disability to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Simple suture
|
Atraumatic exodontia followed by simple suture
|
EXPERIMENTAL: PRGF-Endoret
|
Atraumatic exodontia followed by simple suture
Filling of the alveolus with PRGF clot and fibrin plug.
Preparation of PRGF using Endoret technology following manufacturer instructions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bone regeneration
Time Frame: 12 months
|
Quantity of new bone measured in bone biopsies obtained after alveolar ridge preservation
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 7, 2019
Primary Completion (ANTICIPATED)
December 31, 2023
Study Completion (ANTICIPATED)
December 31, 2023
Study Registration Dates
First Submitted
September 16, 2019
First Submitted That Met QC Criteria
September 16, 2019
First Posted (ACTUAL)
September 18, 2019
Study Record Updates
Last Update Posted (ACTUAL)
May 9, 2022
Last Update Submitted That Met QC Criteria
May 6, 2022
Last Verified
September 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- FIBEA_04_EC_19_ALV
- 2019-001167-75 (EudraCT Number)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Implantation
-
William GiannobileJohnson & JohnsonWithdrawnDental ImplantationUnited States
-
Innovative Implant SolutionsUnknownDental ImplantationIsrael
-
Rambam Health Care CampusRecruiting
-
International Piezosurgery AcademyCompleted
-
Virginia Commonwealth UniversityNational Institute of Dental and Craniofacial Research (NIDCR); Nobel BiocareCompleted
-
Ahram Canadian UniversityAl Hayah University in CairoRecruitingDental Implantation | Dental Implant | Surgical Dental ProsthesesEgypt
-
Samara State Medical UniversityRecruitingDental ImplantationRussian Federation
-
University of LiegeRecruiting
-
Fundación Eduardo AnituaRecruiting
-
Aydin Adnan Menderes UniversityCompletedDental ImplantationTurkey
Clinical Trials on Exodontia
-
Universidad Rey Juan CarlosRecruitingMolar, Third | Periodontal PocketSpain
-
Boston Children's HospitalWithdrawnFocal Infection, Dental
-
Riyadh Colleges of Dentistry and PharmacyCompletedVital Signs Changes During Dental ProceduresSaudi Arabia
-
AbbottCompleted
-
Federal University of Juiz de ForaUnknown